The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from a phase 1b study of blinatumomab-pembrolizumab combination in adults with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
 
Pratyush Giri
No Relationships to Disclose
 
Sushrut Patil
No Relationships to Disclose
 
Sumita Ratnasingam
No Relationships to Disclose
 
H. Miles Prince
No Relationships to Disclose
 
Samuel Milliken
No Relationships to Disclose
 
Javier Briones Meijide
Honoraria - Bristol-Myers Squibb; Kite, a Gilead Company; Novartis; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Kite, a Gilead Company; Novartis; Takeda
 
Luke Coyle
No Relationships to Disclose
 
Marjolein Van Der Poel
Consulting or Advisory Role - Incyte; SERVIER
 
Carolyn M. Mulroney
No Relationships to Disclose
 
Mohammed Z. H. Farooqui
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
Other Relationship - Merck
 
Hansen Wong
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Rajendra Desai
No Relationships to Disclose
 
Gerhard Zugmaier
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Noemi Mergen
Employment - Amgen
 
Paul Cannell
No Relationships to Disclose